TFF Pharmaceuticals

About:

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

Twitter/X: tffpharma

Top Investors: National Institute of Allergy and Infectious Diseases, Liquid Ventures, Leidos Holdings

Description:

TFF Pharmaceuticals an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions. TFF Pharmaceuticals has generated numerous formulations for faster and more complete dry powder delivery to the lungs.

Total Funding Amount:

$72.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2018-01-24

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-04-29

IPO Status:

Public

Industries: